Phase II Multicenter Single-arm Study of BKM120 Plus Capecitabine for Breast Cancer Patients With Brain Metastases
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2018
At a glance
- Drugs Buparlisib (Primary) ; Capecitabine
- Indications Breast cancer
- Focus Therapeutic Use
- 22 Feb 2018 Planned End Date changed from 1 Jan 2018 to 1 Dec 2018.
- 22 Feb 2018 Planned primary completion date changed from 1 Nov 2017 to 1 Dec 2018.
- 29 Sep 2017 Status changed from recruiting to active, no longer recruiting.